99 related articles for article (PubMed ID: 15969059)
1. [The effects of the Smad3-knockout on the hematopoiesis of mouse].
Zhang L; Sun Z; Shen AL; Ma L; Jiang XY; Ma GJ; Yang X; Zhao CH
Sheng Wu Gong Cheng Xue Bao; 2003 Jul; 19(4):428-32. PubMed ID: 15969059
[TBL] [Abstract][Full Text] [Related]
2. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
3. Thy-1 is a differentiation antigen that characterizes immature murine erythroid and myeloid hematopoietic progenitors.
Miller BA; Lipton JM; Linch DC; Burakoff SJ; Nathan DG
J Cell Physiol; 1985 Apr; 123(1):25-32. PubMed ID: 2857726
[TBL] [Abstract][Full Text] [Related]
4. Increased longevity of hematopoiesis in continuous bone marrow cultures and adipocytogenesis in marrow stromal cells derived from Smad3(-/-) mice.
Epperly MW; Cao S; Goff J; Shields D; Zhou S; Glowacki J; Greenberger JS
Exp Hematol; 2005 Mar; 33(3):353-62. PubMed ID: 15730859
[TBL] [Abstract][Full Text] [Related]
5. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells.
Miller CL; Rebel VI; Lemieux ME; Helgason CD; Lansdorp PM; Eaves CJ
Exp Hematol; 1996 Feb; 24(2):185-94. PubMed ID: 8641340
[TBL] [Abstract][Full Text] [Related]
6. Migration of stem cells and progenitors between marrow and spleen following thiamphenicol treatment of mice.
Goris H; Bungart B; Loeffler M; Schmitz S; Nijhof W
Exp Hematol; 1990 Jun; 18(5):400-7. PubMed ID: 2338129
[TBL] [Abstract][Full Text] [Related]
7. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V
Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
[TBL] [Abstract][Full Text] [Related]
8. The opposing actions in vivo on murine myelopoiesis of purified preparations of lactoferrin and the colony stimulating factors.
Broxmeyer HE; Williams DE; Hangoc G; Cooper S; Gentile P; Shen RN; Ralph P; Gillis S; Bicknell DC
Blood Cells; 1987; 13(1-2):31-48. PubMed ID: 3499193
[TBL] [Abstract][Full Text] [Related]
9. Prevention of hematopoietic myeloid and megakaryocyte toxicity associated with zidovudine in vivo in mice with recombinant GM-CSF.
Gallicchio VS; Hughes NK; Tse KF
Growth Regul; 1994 Jun; 4(2):41-7. PubMed ID: 7950902
[TBL] [Abstract][Full Text] [Related]
10. Regulation of early hematopoiesis in serum-deprived cultures of mafosfamide-treated and untreated CD34-enriched bone marrow cells.
Ottmann OG; Stella CC; Eder M; Reutzel P; Ströcker S; Hoelzer D; Ganser A
Exp Hematol; 1991 Sep; 19(8):773-8. PubMed ID: 1714403
[TBL] [Abstract][Full Text] [Related]
11. Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma.
Broxmeyer HE; Benninger L; Cooper S; Hague N; Benjamin RS; Vadhan-Raj S
Exp Hematol; 1995 Apr; 23(4):335-40. PubMed ID: 7895781
[TBL] [Abstract][Full Text] [Related]
12. Reduced oxygen tension increases hematopoiesis in long-term culture of human stem and progenitor cells from cord blood and bone marrow.
Koller MR; Bender JG; Miller WM; Papoutsakis ET
Exp Hematol; 1992 Feb; 20(2):264-70. PubMed ID: 1544397
[TBL] [Abstract][Full Text] [Related]
13. [Promotion of post BMT hematopoiesis reconstitution by cotransplantation of IL-3 transfected marrow stromal cells in mice].
Jiang J; Zhang J; Hao J; Xie S
Zhonghua Xue Ye Xue Za Zhi; 2002 Aug; 23(8):407-10. PubMed ID: 12411043
[TBL] [Abstract][Full Text] [Related]
14. The hematon, a morphogenetic functional complex in mammalian bone marrow, involves erythroblastic islands and granulocytic cobblestones.
Blazsek I; Liu XH; Anjo A; Quittet P; Comisso M; Kim-Triana B; Misset JL
Exp Hematol; 1995 Apr; 23(4):309-19. PubMed ID: 7895780
[TBL] [Abstract][Full Text] [Related]
15. Methods for measuring suppression of hematopoiesis.
Chervenick PA
Exp Hematol; 1985; 13 Suppl 16():8-15. PubMed ID: 3987838
[TBL] [Abstract][Full Text] [Related]
16. Acute toxic effects of 3'-azido-3'-deoxythymidine (AZT) on normal and regenerating murine hematopoiesis.
Scheding S; Media JE; Nakeff A
Exp Hematol; 1994 Jan; 22(1):60-5. PubMed ID: 8282060
[TBL] [Abstract][Full Text] [Related]
17. The effect of natural killer cells on the development of syngeneic hematopoietic progenitors.
Holmberg LA; Miller BA; Ault KA
J Immunol; 1984 Dec; 133(6):2933-9. PubMed ID: 6436368
[TBL] [Abstract][Full Text] [Related]
18. In vitro sensitivity of human hematopoietic progenitor cells to 4-hydroperoxycyclophosphamide.
Ratajczak MZ; Ratajczak J; Kuczynski W; Light B; Lusk EJ; Gewirtz AM
Exp Hematol; 1993 Dec; 21(13):1663-7. PubMed ID: 8243568
[TBL] [Abstract][Full Text] [Related]
19. The effects of transforming growth factor beta 3 on the growth of highly enriched hematopoietic progenitor cells derived from normal human bone marrow and peripheral blood.
Strife A; Lambek C; Perez A; Darzynkiewicz Z; Skierski J; Gulati S; Haley JD; ten Dijke P; Iwata KK; Clarkson BD
Cancer Res; 1991 Sep; 51(18):4828-36. PubMed ID: 1893375
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of tumor necrosis factor on hematopoiesis seen in vitro are translated to increased numbers of both committed and multipotent progenitors in TNF-deficient mice.
Drutskaya MS; Ortiz M; Liepinsh DJ; Kuprash DV; Nedospasov SA; Keller JR
Exp Hematol; 2005 Nov; 33(11):1348-56. PubMed ID: 16263419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
